These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 24769080)

  • 1. Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights.
    Bose P; Dai Y; Grant S
    Pharmacol Ther; 2014 Sep; 143(3):323-36. PubMed ID: 24769080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach.
    Li QQ; Hao JJ; Zhang Z; Hsu I; Liu Y; Tao Z; Lewi K; Metwalli AR; Agarwal PK
    Int J Oncol; 2016 Jun; 48(6):2591-607. PubMed ID: 27082124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDAC inhibitors: roles of DNA damage and repair.
    Robert C; Rassool FV
    Adv Cancer Res; 2012; 116():87-129. PubMed ID: 23088869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitor-mediated cell death is distinct from its global effect on chromatin.
    Luchenko VL; Litman T; Chakraborty AR; Heffner A; Devor C; Wilkerson J; Stein W; Robey RW; Bangiolo L; Levens D; Bates SE
    Mol Oncol; 2014 Dec; 8(8):1379-92. PubMed ID: 24954856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol sensitizes acute myelogenous leukemia cells to histone deacetylase inhibitors through reactive oxygen species-mediated activation of the extrinsic apoptotic pathway.
    Yaseen A; Chen S; Hock S; Rosato R; Dent P; Dai Y; Grant S
    Mol Pharmacol; 2012 Dec; 82(6):1030-41. PubMed ID: 22923501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
    Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
    Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitors potentiate photodynamic therapy in colon cancer cells marked by chromatin-mediated epigenetic regulation of
    Halaburková A; Jendželovský R; Kovaľ J; Herceg Z; Fedoročko P; Ghantous A
    Clin Epigenetics; 2017; 9():62. PubMed ID: 28603560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class I and class II histone deacetylases are potential therapeutic targets for treating pancreatic cancer.
    Wang G; He J; Zhao J; Yun W; Xie C; Taub JW; Azmi A; Mohammad RM; Dong Y; Kong W; Guo Y; Ge Y
    PLoS One; 2012; 7(12):e52095. PubMed ID: 23251689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitors and rational combination therapies.
    Grant S; Dai Y
    Adv Cancer Res; 2012; 116():199-237. PubMed ID: 23088872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing CRISPR/Cas9-mediated homology-directed DNA repair by histone deacetylase inhibitors.
    Li G; Zhang X; Wang H; Liu D; Li Z; Wu Z; Yang H
    Int J Biochem Cell Biol; 2020 Aug; 125():105790. PubMed ID: 32534122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitors: insights into mechanisms of lethality.
    Rosato RR; Grant S
    Expert Opin Ther Targets; 2005 Aug; 9(4):809-24. PubMed ID: 16083344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitors selectively target homology dependent DNA repair defective cells and elevate non-homologous endjoining activity.
    Smith S; Fox J; Mejia M; Ruangpradit W; Saberi A; Kim S; Choi Y; Oh S; Wang Y; Choi K; Li L; Hendrickson EA; Takeda S; Muller M; Myung K
    PLoS One; 2014; 9(1):e87203. PubMed ID: 24466340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDAC Inhibitor Sodium Butyrate Attenuates the DNA Repair in Transformed but Not in Normal Fibroblasts.
    Gnedina OO; Morshneva AV; Skvortsova EV; Igotti MV
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitors and genomic instability.
    Eot-Houllier G; Fulcrand G; Magnaghi-Jaulin L; Jaulin C
    Cancer Lett; 2009 Feb; 274(2):169-76. PubMed ID: 18635312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
    J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors.
    Kortenhorst MS; Wissing MD; Rodríguez R; Kachhap SK; Jans JJ; Van der Groep P; Verheul HM; Gupta A; Aiyetan PO; van der Wall E; Carducci MA; Van Diest PJ; Marchionni L
    Epigenetics; 2013 Sep; 8(9):907-20. PubMed ID: 23880963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An insight into understanding the coupling between homologous recombination mediated DNA repair and chromatin remodeling mechanisms in plant genome: an update.
    Banerjee S; Roy S
    Cell Cycle; 2021 Sep; 20(18):1760-1784. PubMed ID: 34437813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of histone deacetylase inhibitors SAHA and MS-275 on DNA repair pathways in human mesenchymal stem cells.
    Di Bernardo G; Alessio N; Dell'Aversana C; Casale F; Teti D; Cipollaro M; Altucci L; Galderisi U
    J Cell Physiol; 2010 Nov; 225(2):537-44. PubMed ID: 20458754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of the histone deacetylase inhibitors for the treatment of endometriosis: histone modifications as pathogenesis and novel therapeutic target.
    Kawano Y; Nasu K; Li H; Tsuno A; Abe W; Takai N; Narahara H
    Hum Reprod; 2011 Sep; 26(9):2486-98. PubMed ID: 21715447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibitor pre-treatment enhances the efficacy of DNA-interacting chemotherapeutic drugs in gastric cancer.
    Amnekar RV; Khan SA; Rashid M; Khade B; Thorat R; Gera P; Shrikhande SV; Smoot DT; Ashktorab H; Gupta S
    World J Gastroenterol; 2020 Feb; 26(6):598-613. PubMed ID: 32103870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.